Charles River Laboratories International (CRL) Depreciation and Depletion (2016 - 2025)
Charles River Laboratories International has reported Depreciation and Depletion over the past 15 years, most recently at $45.1 million for Q4 2025.
- Quarterly results put Depreciation and Depletion at $45.1 million for Q4 2025, down 6.82% from a year ago — trailing twelve months through Dec 2025 was $177.6 million (down 6.62% YoY), and the annual figure for FY2025 was $177.6 million, down 6.62%.
- Depreciation and Depletion for Q4 2025 was $45.1 million at Charles River Laboratories International, up from $44.8 million in the prior quarter.
- Over the last five years, Depreciation and Depletion for CRL hit a ceiling of $155.6 million in Q4 2022 and a floor of $559000.0 in Q1 2022.
- Median Depreciation and Depletion over the past 5 years was $44.4 million (2023), compared with a mean of $42.1 million.
- Peak annual rise in Depreciation and Depletion hit 7878.53% in 2023, while the deepest fall reached 70.12% in 2023.
- Charles River Laboratories International's Depreciation and Depletion stood at $138.6 million in 2021, then rose by 12.28% to $155.6 million in 2022, then crashed by 70.12% to $46.5 million in 2023, then grew by 4.09% to $48.4 million in 2024, then dropped by 6.82% to $45.1 million in 2025.
- The last three reported values for Depreciation and Depletion were $45.1 million (Q4 2025), $44.8 million (Q3 2025), and $44.3 million (Q2 2025) per Business Quant data.